Clinical Report: Understanding Precocious Puberty in Males: Recent Advances
Background
Central precocious puberty (CPP) in males is a condition characterized by the early activation of the hypothalamic-pituitary-gonadal (HPG) axis, leading to testicular enlargement before age 9. Historically, CPP was linked to a high prevalence of intracranial lesions, observed in 40-50% of cases. Recent data suggest a shift towards idiopathic cases, necessitating updated diagnostic approaches and risk assessments.
Data Highlights
No numerical data available in the source material.
Key Findings
CPP in males is clinically diagnosed by testicular volume >4 mL before age 9.
Prevalence of brain lesions in males with CPP has decreased to approximately 6-8%.
Identified risk factors for intracranial lesions include neurological symptoms and early pubertal onset.
Idiopathic CPP is the majority of cases, with genetic mutations in KISS1, KISS1R, MKRN3, and DLK1 implicated.
Environmental exposures, particularly to endocrine-disrupting chemicals, may influence pubertal timing.
Clinical Implications
The findings suggest a need for a more selective approach to neuroimaging in boys with CPP, focusing on those with specific risk factors. Clinicians should consider genetic testing and environmental factors when evaluating cases of CPP.
Conclusion
CPP in boys is influenced by a complex interplay of genetic and environmental factors, necessitating updated diagnostic and management strategies.
